Phase 2 BELIEVE study part B: Efficacy and safety of rilzabrutinib for patients with pemphigus vulgaris.

D F MurrellAikaterini PatsatsiP StavropoulosS BaumT ZeeliJ S KernR SinclairA NealeP AroraP B SugermanG ShiV P WerthFrédéric Caux Pascal Jolynull null

Published in: Journal of the European Academy of Dermatology and Venereology : JEADV (2022)

Keyphrases